In my view, the most positive release yet, noting;
x Phase 3 trial still on track
x meeting with FDA and finalisation of IND applications for 3 x 2591 phase 2 trials on schedule.
x manufacturing of 2591 continuing for 3 x phase 2 trials. This point and the one above can only mean the phase 1 trial was successful. We will kmow next week I reckon...
x explicitly called out China for deals, and noted that any deal is not factored into any of the analyst reports. Another good lead.....
Trading in Neuren has been a bit bumpy, but I think smmothe roads are ahead. Good luck all!
Ann: Quarterly report and cash flow statement for Q4 2020, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |